In this respect, early treatment of dry AMD may potentially prevent its progression to the neovascular form, that is usually treated by intravitreal injections of anti-vascular endothelial growth factor (VEGF) molecules. The gene discussed is VEGFA; the disease is dry age related macular degeneration.